The latest report by IMARC Group, titled “Intravenous Solutions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022”, finds that the global intravenous solution market reached a value of more than US$ 7 Billion in 2016. Intravenous solutions refer to the fluids which are administrated into a vein by means of a steel needle or plastic catheter. They are a combination of essential nutrients that helps in sustaining strength, facilitating faster recovery and maintaining hydration levels in patients. Intravenous solutions also help in the homeostasis of the body by maintaining its fluid and electrolyte balance. In addition to this, they are extensively used by the geriatric population and to treat people suffering from conditions like diabetes and cancer, and unhealthy eating habits.
Highlights of the global intravenous solutions market:
- Portable packaging of intravenous solutions is expected to be the major demand driver.
- North America represents the largest producer, accounting for the majority of the global production.
- The market is projected to reach a value of around US$ 11 Billion by 2022.
The major factor driving the growth of the intravenous solutions market is the availability of intravenous products in portable packaging which makes it easier for consumers to use them in a home setting as well. Additionally, through innovation, vendors are able to offer premixed products for increased convenience and reduced waste and disposal costs which is further likely to impact the market growth. Further, with the rising prevalence of chronic diseases and gastrointestinal disorders, the adoption of intravenous solutions is rising among the consumers. Moreover, the governments in the developing countries are increasing the investment in the healthcare sector, thereby driving the demand for intravenous solutions. According to the report, the global intravenous solutions market is expected to reach a value of around US$ 11 Billion by 2022, exhibiting a CAGR of 6.5% during 2017-2022.
Request a free sample copy of the report: https://www.imarcgroup.com/request?type=report&id=891&flag=B
On the basis of product type, the market is segmented into partial and total parenteral nutrition. The market is further segregated on the basis of nutrients into carbohydrates, salts and electrolytes, minerals, vitamins and amino acids. Based on region, North America currently holds the majority of the global intravenous solutions market, followed by Europe and Asia Pacific. Other major regions include the Middle East and Africa, and Latin America. On evaluating the competitive landscape of the market, it is found that the major players are Ajinomoto, B. Braun Melsungen, Baxter International Inc., Grifols and Otsuka Pharmaceutical.
The report by IMARC Group has examined the global intravenous solutions market on the basis of:
- Partial Parenteral Nutrition
- Total Parenteral Nutrition
- Salts and Electrolytes
- Amino Acids
- North America
- Asia Pacific
- Middle East and Africa
- Latin America
- B. Braun Melsungen
- Baxter International Inc.
- Otsuka Pharmaceutical
Browse related reports:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Company Name: IMARC Group
Contact Person: Anand Ranjan
Country: United States